SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-003104
Filing Date
2017-05-01
Accepted
2017-05-01 17:26:42
Documents
10
Period of Report
2017-06-19
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231985zdef14a.htm DEF 14A 585765
2 G150899.JPG g150899.jpg GRAPHIC 11755
3 G28654.JPG g28654.jpg GRAPHIC 6567
4 G407006.JPG g407006.jpg GRAPHIC 5158
5 G23602BGI001.GIF g23602bgi001.gif GRAPHIC 82101
6 G23602BGI002.GIF g23602bgi002.gif GRAPHIC 71723
7 G23602BII001.GIF g23602bii001.gif GRAPHIC 151489
8 G23602BII002.GIF g23602bii002.gif GRAPHIC 73158
9 G23602BKI001.GIF g23602bki001.gif GRAPHIC 154678
10 G23602BKI002.GIF g23602bki002.gif GRAPHIC 174375
  Complete submission text file 0001047469-17-003104.txt   1594496
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35619 | Film No.: 17802063
SIC: 2834 Pharmaceutical Preparations